Results 181 to 190 of about 72,546 (336)

Extraosseous primary and recurrent giant cell tumors: Transforming growth factor-β1 and -β2 expression may explain metaplastic bone formation

open access: hybrid, 1996
Lisa A. Teot   +5 more
openalex   +1 more source

Interphase cytogenetics of precancerous and neoplastic human testicular germ cells [PDF]

open access: yes, 1990
Burger, Georg   +4 more
core   +1 more source

Recent developments in eosinophilic renal neoplasms: what's new, true and important?

open access: yesHistopathology, Volume 88, Issue 1, Page 166-192, January 2026.
Recent developments and acquired knowledge on newer renal entities with eosinophilic cytoplasm opened insights into the clinical, pathological, immunohistochemical, molecular, epidemiological aspects, and the prognosis of these entities. We emphasize the role of routine morphology, aided by appropriate and select immunohistochemistry, as essential keys
Kiril Trpkov   +2 more
wiley   +1 more source

Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants

open access: gold
Floortje G M Verspoor   +4 more
openalex   +1 more source

Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κB [PDF]

open access: bronze, 2005
Teresa Morgan   +12 more
openalex   +1 more source

The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate

open access: yesHistopathology, Volume 88, Issue 1, Page 8-23, January 2026.
The GUPS–ISUP joint expert consultation on IDCP provides unified recommendations for the diagnosis, terminology, grading, and reporting of IDCP and atypical intraductal proliferation. Their adoption should reduce interobserver variation, facilitate consistent communication with clinicians, and improve patient management.
Rajal B Shah   +31 more
wiley   +1 more source

Assessment of Surgical Downstaging in an Open-Label Phase 2 Trial of Denosumab in Patients with Giant Cell Tumor of Bone

open access: bronze, 2014
Stefano Ferrari   +9 more
openalex   +1 more source

Safety of Exogenous Recombinant Human Platelet‐Derived Growth Factor‐BB (rhPDGF‐BB) for Medical and Cosmetic Applications: A Review

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Recombinant human platelet‐derived growth factor‐BB (rhPDGF‐BB or pure PDGF) has been extensively studied in medicine, resulting in four FDA approvals for products based on pure PDGF for tissue regeneration applications, including stimulation of the healing of skin wounds in diabetic patients, stimulation of healing of intra‐oral ...
Christopher K. Hee   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy